Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology NMIBC data

<< Previous

Bullboard Posts

Next >>

Comment by Gman620on Dec 02, 2022 10:21am

188 Views

Post# 35146185

RE:RE:RE:RE:RE:CG Oncology NMIBC data

Right. But the behavior of the FDA is also suspect. I feel there is a 'wink' that if you piggyback on (combo with) Keytruda, you get a 'fast pass' to the head of the line for BTD, etc. Anything to sell more Keytruda is good and is an easy road.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages